First in Human Study of KO-539 in Relapsed or Refractory Acute Myeloid Leukemia
Condition: Advanced Malignant Neoplasm Intervention: Drug: KO-539 Sponsor: Kura Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Leukemia | Research | Study